Tech Company Financing Transactions

Mahana Therapeutics Funding Round

Gurnet Point Capital, JAZZ Venture Partners and KKCG participated in a $61 million Series B capital raise for Mahana Therapeutics. The financing was announced on 8/12/2021.

Transaction Overview

Announced On
8/12/2021
Transaction Type
Venture Equity
Amount
$61,000,000
Round
Series B
Proceeds Purpose
The company will use the funds to launch the FDA-cleared prescription digital therapeutic Mahana� IBS and accelerate development of several digital therapeutics for chronic health conditions.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1 Market Spear Tower 36th Floor
San Francisco, CA 94105
USA
Phone
Undisclosed
Email Address
Overview
Mahana Therapeutics is a digital therapeutics company. Digital therapeutics are treatment options that use internet- and mobile-based technologies to improve clinical outcomes, quality of life and well-being.
Profile
Mahana Therapeutics LinkedIn Company Profile
Social Media
Mahana Therapeutics Company Twitter Account
Company News
Mahana Therapeutics News
Facebook
Mahana Therapeutics on Facebook
YouTube
Mahana Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steven Basta
  Steven Basta LinkedIn Profile  Steven Basta Twitter Account  Steven Basta News  Steven Basta on Facebook
Chief Marketing Officer
Soren Mills
  Soren Mills LinkedIn Profile  Soren Mills Twitter Account  Soren Mills News  Soren Mills on Facebook
Chief Technical Officer
Simon Levy
  Simon Levy LinkedIn Profile  Simon Levy Twitter Account  Simon Levy News  Simon Levy on Facebook
VP - Finance
Myla Puyat
  Myla Puyat LinkedIn Profile  Myla Puyat Twitter Account  Myla Puyat News  Myla Puyat on Facebook
VP - Marketing
Kelly Price
  Kelly Price LinkedIn Profile  Kelly Price Twitter Account  Kelly Price News  Kelly Price on Facebook
VP - Operations
Adam Hardin
  Adam Hardin LinkedIn Profile  Adam Hardin Twitter Account  Adam Hardin News  Adam Hardin on Facebook
VP - Product Management
Ann Montgomery
  Ann Montgomery LinkedIn Profile  Ann Montgomery Twitter Account  Ann Montgomery News  Ann Montgomery on Facebook
VP - Regulatory Affairs
Kendal Dinsmore
  Kendal Dinsmore LinkedIn Profile  Kendal Dinsmore Twitter Account  Kendal Dinsmore News  Kendal Dinsmore on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/12/2021: Tessian venture capital transaction
Next: 8/12/2021: AviaGames venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary